Document is current
Any future updates will be listed below
-
Authors
Chupin, Caroline
Brun, Pauline
Ray, Marjorie
Mialon, Chloé
Reitano, Maëlle
Traversier, Aurélien
Laurent, Emilie
Goumaidi, Abdelghafar
Fouret, Julien
Paul, Stéphane
Boukhvalova, Marina
Yim, Kevin
Blanco, Jorge
Hamelin, Marie-Eve
Boivin, Guy
Rosa-Calatrava, Manuel
Dubois, Julia
-
Funding
Funding for this research was provided by:
Association Nationale de la Recherche et de la Technologie (CIFRE 2019-3307)
National Institute of Allergy and Infectious Diseases (HHSN272201700028I / 75N93023F00001 / A88HHSN272201700028I / 75N93023F00001 / A88, HHSN272201700028I / 75N93023F00001 / A88HHSN272201700028I / 75N93023F00001 / A88, HHSN272201700028I / 75N93023F00001 / A88HHSN272201700028I / 75N93023F00001 / A88)
Canadian Institutes of Health Research (148361)
Université Laval (RESPIVIR)
Agence Nationale de la Recherche (ANR AAP19 METAVAC-T17)
Région Auvergne-Rhône-Alpes (R &D booster METABIOSE)
Centre National de la Recherche Scientifique (International Research Program RESPIVIR)
Institut National de la Santé et de la Recherche Médicale (Jointlab program RESPIVIR)
Université Claude Bernard Lyon 1 (RESPIVIR)
- License Information
-
More Information
Article History
Received: 13 March 2025
Accepted: 14 July 2025
First Online: 22 August 2025
Competing interests
: Manuel Rosa-Calatrava, Guy Boivin, Julia Dubois, and Marie-Eve Hamelin are co-founders and shareholders of Vaxxel SAS. Caroline Chupin is currently an employee of Vaxxel SAS and Marjorie Ray was an employee of Vaxxel SAS. The remaining authors declare no competing interests. The authors declare the following patent : EP22305240.2 – PCT/EP2023/055221 concerning vaccine composition against two respiratory viruses (Inventors: Daniela Ogonczyk-Makowska, Jean-François Eléouët, Guy Boivin, Julia Dubois, and Manuel Rosa-Calatrava ; Applicants : Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Claude Bernard Lyon 1 (UCBL) Ecole Normale Supérieure de Lyon (ENS Lyon), Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE) and Vaxxel SAS).
